The Patent Finder

Progen Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Progen Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Progen Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 7,875,592Sulfated oligosaccharide derivatives
Formerly held
Lapsed on the fee record
Ended Jan 25, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jan 25, 2023From the USPTO record
US 9,527,805Small Molecules as Epigenetic Modulators of Lysine-Specific Demethylase 1 and Methods of Treating Disorders
Formerly held
Lapsed on the fee record
Ended Dec 27, 2020 · High confidence
Lapsed on the fee recordEnded Dec 27, 2020High confidence
US 8,173,606Sulfated oligosaccharide derivatives
Formerly held
Lapsed on the fee record
Ended May 8, 2020 · From the USPTO record
Lapsed on the fee recordEnded May 8, 2020From the USPTO record
US 8,828,952Novel Sulfated Oligosaccharide Derivatives
Formerly held
Surrendered on reissue
Surrendered on reissue Jul 17, 2018 · Low confidence
Surrendered on reissueSurrendered on reissue Jul 17, 2018Low confidence
US 8,623,833Compositions and methods for enhancing drug delivery across and into epithelial tissues
Formerly held
Lapsed on the fee record
Ended Jan 7, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jan 7, 2018From the USPTO record
US 7,585,834Transporters Comprising Spaced Arginine Moieties
Formerly held
Lapsed on the fee record
Ended Sep 8, 2017 · Medium confidence
Lapsed on the fee recordEnded Sep 8, 2017Medium confidence
US 8,278,264Compositions and methods for enhancing drug delivery across and into ocular tissues
Formerly held
Lapsed on the fee record
Ended Oct 2, 2016 · From the USPTO record
Lapsed on the fee recordEnded Oct 2, 2016From the USPTO record
US 6,759,387Compositions and methods for enhancing drug delivery across and into epithelial tissues
Formerly held
Lapsed on the fee record
Ended Jul 6, 2016 · From the USPTO record
Lapsed on the fee recordEnded Jul 6, 2016From the USPTO record
US 6,730,293Compositions and methods for treating inflammatory diseases of the skin
Formerly held
Lapsed on the fee record
Ended May 4, 2016 · From the USPTO record
Lapsed on the fee recordEnded May 4, 2016From the USPTO record
US 6,669,951Compositions and methods for enhancing drug delivery across and into epithelial tissues
Formerly held
Lapsed on the fee record
Ended Dec 30, 2015 · From the USPTO record
Lapsed on the fee recordEnded Dec 30, 2015From the USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited